Cargando…
Correction: HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry
Autores principales: | Eggink, Dirk, Bontjer, Ilja, de Taeye, Steven W., Langedijk, Johannes P.M., Berkhout, Ben, Sanders, Rogier W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918835/ https://www.ncbi.nlm.nih.gov/pubmed/35290891 http://dx.doi.org/10.1016/j.jbc.2022.101811 |
Ejemplares similares
-
HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry
por: Eggink, Dirk, et al.
Publicado: (2019) -
Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts.
por: Sharma, Vandana, et al.
Publicado: (2011) -
Correction: Potentiation of tumor necrosis factor-α-induced tumor cell apoptosis by a small molecule inhibitor for anti-apoptotic protein hPEBP4
por: Qiu, Jianming, et al.
Publicado: (2021) -
Structural and dynamical features of inteins and implications on protein splicing.
por: Eryilmaz, Ertan, et al.
Publicado: (2014) -
Doc toxin is a kinase that inactivates elongation factor Tu.
por: Cruz, Jonathan W., et al.
Publicado: (2014)